HBIO
HARVARD BIOSCIENCE INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$7.95
−1.00%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.17
- Revenue estimate
- $21.8M
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.14
- EPS estimate
- -$0.21
- Revenue actual
- $22.7M
- Revenue estimate
- $21.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -495.2%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.21 | -$0.14 | Beat 33.33% | $22.7M |
| May 12, 2026 | -$0.62 | -$0.33 | Beat 46.77% | $20.8M |
| Mar 12, 2026 | $0.04 | -$0.64 | Miss -1932.43% | $23.7M |
| Nov 6, 2025 | $0.04 | -$0.01 | Miss -128.57% | $20.6M |
| Mar 12, 2025 | $0.05 | $0.06 | Beat 20.00% | $24.6M |
| Nov 7, 2024 | $0.05 | -$0.02 | Miss -140.00% | $22.0M |
| Aug 8, 2024 | $0.05 | -$0.03 | Miss -160.00% | $23.1M |
| Mar 7, 2024 | $0.05 | $0.04 | Miss -20.00% | $28.2M |
| Mar 9, 2023 | $0.03 | $0.04 | Beat 20.01% | $28.4M |
| Aug 3, 2022 | $0.06 | $0.05 | Miss -16.67% | $29.2M |
| May 4, 2022 | $0.05 | $0.04 | Miss -20.00% | $28.8M |
| Mar 8, 2022 | $0.09 | $0.08 | Miss -11.11% | $33.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026